Repeat dose study of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD)

Trial Identifier: 207972
Sponsor: GlaxoSmithKline
Start Date: April 2018
Primary Completion Date: October 2019
Study Completion Date: January 2020
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
France Brest Cedex, France, 29609
France Montpellier cedex 5, France, 34295
France Nantes cedex 1, France, 44093
Netherlands AMSTERDAM, Netherlands, 1105 AZ
Russian Federation Izhevsk, Russian Federation, 426063
Russian Federation Kemerovo, Russian Federation, 650000
Russian Federation Moscow, Russian Federation, 115478
Russian Federation Moscow, Russian Federation, 105275
Russian Federation Saint Petersburg, Russian Federation, 194291
Russian Federation Saint Petersburg, Russian Federation, 196240
Russian Federation Saint-Petersburg, Russian Federation, 194354
Russian Federation Ulyanovsk, Russian Federation, 432063
United Kingdom Birmingham, United Kingdom, B9 5SS
United Kingdom Bradford, United Kingdom, BD9 6RJ
United Kingdom Edgbaston, United Kingdom, B15 2GW
United Kingdom, Greater Manchester Wythenshawe, Greater Manchester, United Kingdom, M23 9LT
United Kingdom, Leicestershire Leicester, Leicestershire, United Kingdom, LE3 9QP
United Kingdom, Merseyside Liverpool, Merseyside, United Kingdom, L7 8XP